Sign up to save your podcasts
Or
Share How do steroid cycles affect cholesterol and lipid profiles?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
How do steroid cycles affect cholesterol and lipid profiles?
Get your stacks at https://www.publichealthlaw.best/podcast-stacks now! If you want to learn more about anabolics, SARMs, prohormones visit us at: https://www.publichealthlaw.best/
Q1: How do anabolic-androgenic steroid (AAS) cycles typically affect cholesterol levels?
Anabolic-androgenic steroids, particularly oral preparations and certain injectable ones, are known to negatively impact cholesterol levels. A common observation is a significant decrease in high-density lipoprotein cholesterol (HDL-C), often referred to as "good" cholesterol. Simultaneously, there can be an increase in low-density lipoprotein cholesterol (LDL-C), known as "bad" cholesterol. This shift in the HDL-C to LDL-C ratio is considered atherogenic, meaning it promotes the buildup of plaque in the arteries, increasing the risk of cardiovascular disease.
Q2: Which types of steroids have the most pronounced negative effects on lipid profiles?
Oral anabolic steroids, especially those that are alkylated at the 17-alpha carbon (to survive liver metabolism), tend to have a more significant negative impact on lipid profiles compared to injectable steroids. This is largely due to their direct effects on liver enzymes involved in lipoprotein metabolism. Among injectables, those with a strong androgenic nature may also lead to more unfavorable lipid changes. The dosage and duration of the steroid cycle also play a crucial role, with higher doses and longer cycles generally correlating with more pronounced negative effects.
Q3: What are the underlying mechanisms by which steroids alter cholesterol and lipid profiles?
The exact mechanisms are complex and not fully understood, but several factors are believed to contribute. Steroids can interfere with the activity of hepatic lipase, an enzyme that breaks down HDL-C. They can also influence the production and secretion of lipoproteins by the liver. Furthermore, steroids may affect the expression of genes involved in lipid metabolism. The specific steroid, its route of administration, and its metabolic byproducts can all influence these pathways differently.
View all episodes
By Justin LosierGet your stacks at https://www.publichealthlaw.best/podcast-stacks now! If you want to learn more about anabolics, SARMs, prohormones visit us at: https://www.publichealthlaw.best/
Q1: How do anabolic-androgenic steroid (AAS) cycles typically affect cholesterol levels?
Anabolic-androgenic steroids, particularly oral preparations and certain injectable ones, are known to negatively impact cholesterol levels. A common observation is a significant decrease in high-density lipoprotein cholesterol (HDL-C), often referred to as "good" cholesterol. Simultaneously, there can be an increase in low-density lipoprotein cholesterol (LDL-C), known as "bad" cholesterol. This shift in the HDL-C to LDL-C ratio is considered atherogenic, meaning it promotes the buildup of plaque in the arteries, increasing the risk of cardiovascular disease.
Q2: Which types of steroids have the most pronounced negative effects on lipid profiles?
Oral anabolic steroids, especially those that are alkylated at the 17-alpha carbon (to survive liver metabolism), tend to have a more significant negative impact on lipid profiles compared to injectable steroids. This is largely due to their direct effects on liver enzymes involved in lipoprotein metabolism. Among injectables, those with a strong androgenic nature may also lead to more unfavorable lipid changes. The dosage and duration of the steroid cycle also play a crucial role, with higher doses and longer cycles generally correlating with more pronounced negative effects.
Q3: What are the underlying mechanisms by which steroids alter cholesterol and lipid profiles?
The exact mechanisms are complex and not fully understood, but several factors are believed to contribute. Steroids can interfere with the activity of hepatic lipase, an enzyme that breaks down HDL-C. They can also influence the production and secretion of lipoproteins by the liver. Furthermore, steroids may affect the expression of genes involved in lipid metabolism. The specific steroid, its route of administration, and its metabolic byproducts can all influence these pathways differently.